OBESITY TYPE 2 DIABETES MELLITUS

Clinical trials for OBESITY TYPE 2 DIABETES MELLITUS explained in plain language.

Never miss a new study

Get alerted when new OBESITY TYPE 2 DIABETES MELLITUS trials appear

Sign up with your email to follow new studies for OBESITY TYPE 2 DIABETES MELLITUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 7 Not yet recruiting 5 Not yet finished but already full! 1 Completed 5

New pill aims to help people with diabetes shed pounds and control blood sugar

Disease control Ongoing

This study tests a new daily pill, aleniglipron, in 58 adults with type 2 diabetes who are overweight or obese. The main goal is to check if the drug is safe and tolerable at different doses. Researchers will also measure weight loss and blood sugar changes. The study is not yet …

Matched conditions: OBESITY TYPE 2 DIABETES MELLITUS

Phase: PHASE2 • Sponsor: Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics • Aim: Disease control

Last updated Jun 27, 2026 12:25 UTC

OBESITY TYPE 2 DIABETES MELLITUS

Get alerted when new OBESITY TYPE 2 DIABETES MELLITUS trials appear

New pill aims to help people with diabetes shed pounds and control blood sugar